ES8504938A1 - Un metodo de producir una proteina interferon inmune humano - Google Patents

Un metodo de producir una proteina interferon inmune humano

Info

Publication number
ES8504938A1
ES8504938A1 ES527414A ES527414A ES8504938A1 ES 8504938 A1 ES8504938 A1 ES 8504938A1 ES 527414 A ES527414 A ES 527414A ES 527414 A ES527414 A ES 527414A ES 8504938 A1 ES8504938 A1 ES 8504938A1
Authority
ES
Spain
Prior art keywords
human immune
immune interferon
interferon protein
production
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527414A
Other languages
English (en)
Other versions
ES527414A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES8504938A1 publication Critical patent/ES8504938A1/es
Publication of ES527414A0 publication Critical patent/ES527414A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

METODO DE PRODUCCION DE UNA PROTEINA INTERFERON HUMANO.SE REALIZA DESARROLLANDO UN TRANSFORMANTE CON ADN QUE CONTIENE UNA SECUENCIA BASICA QUE CODIFICA INTERFERON INMUNE HUMANO, PURIFICANDO EL LIQUIDO OBTENIDO CON ANTICUERPO MONOCLONAL CAPAZ DE UNIRSE A INTERFERON INMUNE HUMANO. EL ADN QUE CODIFICA I-IF HUMANO PUEDE PRODUCIRSE CULTIVANDO CELULAS SECRETORAS DE I-IF HUMANO, TALES COMO LINFOCITOS SANGUINEOS PERIFERICOS HUMANOS. EL INDUCTOR DE I-IF PUEDE SELECCIONARSE DE ENTRE FITOHEMAGLUTININA (PHA), CONCANAVALINA (CONA), ENTEROTOXINA DE ESTAFILOCOCO A (SEA), NEURAMINIDASA-GALACTOSA OXIDASA (NAGO) Y 12-O-TETRADECANOILFORBOL-13-ACETATO (TPA).DE APLICACION COMO SUSTANCIAS ANTIVIRICAS Y ANTITUMORES.
ES527414A 1982-11-22 1983-11-21 Un metodo de producir una proteina interferon inmune humano Granted ES527414A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000445 WO1984002129A1 (en) 1982-11-22 1982-11-22 Human immune interferon protein and process for its preparation

Publications (2)

Publication Number Publication Date
ES8504938A1 true ES8504938A1 (es) 1985-04-16
ES527414A0 ES527414A0 (es) 1985-04-16

Family

ID=13762365

Family Applications (1)

Application Number Title Priority Date Filing Date
ES527414A Granted ES527414A0 (es) 1982-11-22 1983-11-21 Un metodo de producir una proteina interferon inmune humano

Country Status (18)

Country Link
EP (1) EP0110044A1 (es)
JP (4) JPS59186995A (es)
KR (1) KR920001377B1 (es)
AU (1) AU570219B2 (es)
DK (1) DK164063C (es)
ES (1) ES527414A0 (es)
FI (1) FI81832C (es)
GR (1) GR79035B (es)
HU (1) HU209152B (es)
IE (1) IE57053B1 (es)
IL (1) IL69791A (es)
MC (1) MC1553A1 (es)
NO (1) NO169725C (es)
NZ (1) NZ205667A (es)
PH (1) PH20024A (es)
PT (1) PT77573B (es)
WO (1) WO1984002129A1 (es)
ZA (1) ZA837057B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
DE3484374D1 (de) * 1983-08-04 1991-05-08 Green Cross Corp Gamma-interferonzusammensetzung.
JPS6034919A (ja) * 1983-08-04 1985-02-22 Green Cross Corp:The ガンマ・インタ−フェロン組成物
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
FR2556365B1 (fr) * 1983-12-09 1987-07-31 Transgene Sa Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon
DE3426077A1 (de) * 1984-07-14 1986-01-23 Dr. Karl Thomae Gmbh, 7950 Biberach Monoklonale antikoerper gegen humanes ifn-(gamma), diese antikoerper produzierende hybridzellinien, verwendung der neuen antikoerper und verfahren zu deren herstellung
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
JPH0653067B2 (ja) * 1984-09-11 1994-07-20 武田薬品工業株式会社 新規ハイブリドーマおよびその製造法
GB2164650A (en) * 1984-09-25 1986-03-26 Fujisawa Pharmaceutical Co Process for production of y-interferon
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
US4873312A (en) * 1985-04-25 1989-10-10 Amgen Method for purifying interferon and composition of matter produced thereby
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
GB8719108D0 (en) * 1987-08-12 1987-09-16 Natural Environment Res Expression vectors
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
US7230081B1 (en) 1999-11-12 2007-06-12 Maxygen Holdings, Ltd. Interferon gamma conjugates
CA2390292A1 (en) 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Interferon gamma conjugates
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
CA2491178A1 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
CA2593964A1 (en) 2004-12-23 2006-06-29 Molmed Spa Conjugation product
RU2498991C2 (ru) 2007-10-30 2013-11-20 Дженентек, Инк. Очистка антител с помощью катионообменной хроматографии

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376821A (en) * 1981-04-17 1983-03-15 Meloy Laboratories, Inc. Production of human IFN-gamma (immune) interferon
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548U (ja) * 1982-01-22 1983-07-28 株式会社東海理化電機製作所 自動車用ミラ−の駆動装置
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JP2526750B2 (ja) * 1991-07-30 1996-08-21 株式会社ユアサコーポレーション リチウム二次電池

Also Published As

Publication number Publication date
DK164063C (da) 1992-09-28
MC1553A1 (fr) 1984-08-31
DK164063B (da) 1992-05-04
GR79035B (es) 1984-10-02
NZ205667A (en) 1987-01-23
EP0110044A1 (en) 1984-06-13
FI833525A0 (fi) 1983-09-29
IL69791A (en) 1994-05-30
JPS63211240A (ja) 1988-09-02
FI81832B (fi) 1990-08-31
DK430683A (da) 1984-05-23
FI81832C (fi) 1990-12-10
JPH06316532A (ja) 1994-11-15
HU209152B (en) 1994-03-28
NO833659L (no) 1984-05-23
NO169725B (no) 1992-04-21
PT77573B (en) 1986-03-18
AU570219B2 (en) 1988-03-10
PT77573A (en) 1983-11-01
JPS59186995A (ja) 1984-10-23
IE57053B1 (en) 1992-04-08
AU1934683A (en) 1984-06-28
KR840006676A (ko) 1984-12-01
KR920001377B1 (ko) 1992-02-11
WO1984002129A1 (en) 1984-06-07
DK430683D0 (da) 1983-09-21
IE832216L (en) 1984-05-22
ES527414A0 (es) 1985-04-16
PH20024A (en) 1986-09-01
JPS6411639B2 (es) 1989-02-27
JPS59220190A (ja) 1984-12-11
FI833525A (fi) 1984-05-23
ZA837057B (en) 1984-04-25
NO169725C (no) 1992-07-29
JPH0536414B2 (es) 1993-05-31

Similar Documents

Publication Publication Date Title
ES8504938A1 (es) Un metodo de producir una proteina interferon inmune humano
HK1008823A1 (en) Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
ES2006941A6 (es) Un metodo de producir un peptido o una proteina relacionados con un epitope de virus asociado a linfoadenopatiasnvirus de leucemia de celulas t humanas (lavnhtlv-iii).
CA2095852A1 (en) Proteins with changed epitopes and methods for the production thereof
DE3380697D1 (en) Monoclonal antibody
HUT61591A (en) Process for producing haemoglobin and its analogs
DE3650322D1 (de) Fusionsproteine aus Interleukin-2 und Hirudin.
EP0120551A3 (en) Yeast expression systems with vectors having gapdh or pyk promoters, and synthesis of foreign proteins
ES8500996A1 (es) Meotod de producir un polipeptido.
EP0790255A3 (en) Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
MY104673A (en) Binding proteins for insulin-like growth factors.
HK206196A (en) Acid-labile subunit (ALS) of insulin-like-growth factor (IGF) binding protein complex
NZ216737A (en) Dna sequence, transformed cells and expressed proteins antigenic to anti-bovine diarrhea virus antibodies
ES2056753A6 (es) Un procedimiento para la produccion de un polipeptido que tiene actividad de factor quemotactico de monocitos humanos.
IL92685A0 (en) Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them
EP0149241A3 (en) Dna base sequence containing regions involved in the production and secretion of a protein, recombinant dna including the whole or a part of the dna base sequence, and method of producing proteins by use of the recombinant dna
GB2168355B (en) Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
NZ222006A (en) Monoclonal antibodies specific to omega-ifn
EP0343132A3 (en) Methods and systems for producing hiv antigens
NZ209588A (en) Production of human immune interferon and pharmaceutical composition
JPS6427495A (en) Novel physiologically active polypeptide
ES8703928A1 (es) Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20011110